Anti-aldosterones save lives in STEMI heart attack patients: ALBATROSS, REMINDER

(European Society of Cardiology) Certain heart attack patients who have ST-segment elevation myocardial infarction (STEMI) are significantly more likely to survive if they are treated immediately with anti-aldosterone-type drugs in addition to standard therapy, according to new research presented at ESC Congress today.